Stay updated with breaking news from Johnathon Gorman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DOACs were just as effective as warfarin in preventing future thrombotic events in patients with cerebral venous thrombosis stroke, with less major bleeding, in the retrospective ACTION-CVT study.
Findings of ACTION-CVT provide some reassurance
The results provide reassurance that using DOACs for patients with CVT “is not an unreasonable approach,” one expert says.